Elixinol Wellness (Germany) Top Insiders

E8M Stock  EUR 0.02  0  10.00%   
Elixinol Wellness employs about 16 people. The company is managed by 16 executives with a total tenure of roughly 47 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Elixinol Wellness' management performance can provide insight into the company performance.
Oliver Horn  CEO
Chief Executive Officer, Director
Leif Harrison  CEO
Chief Executive Officer of America
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Elixinol Wellness Management Team Effectiveness

The company has return on total asset (ROA) of (0.3266) % which means that it has lost $0.3266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7075) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Wellness' management efficiency ratios could be used to measure how well Elixinol Wellness manages its routine affairs as well as how well it operates its assets and liabilities.

Elixinol Wellness Workforce Comparison

Elixinol Wellness Limited is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 164,456. Elixinol Wellness adds roughly 16.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (1.72) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.63.

Elixinol Wellness Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Elixinol Wellness Price Series Summation is a cross summation of Elixinol Wellness price series and its benchmark/peer.

Elixinol Wellness Notable Stakeholders

An Elixinol Wellness stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elixinol Wellness often face trade-offs trying to please all of them. Elixinol Wellness' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elixinol Wellness' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Oliver HornChief Executive Officer, DirectorProfile
Leif HarrisonChief Executive Officer of AmericaProfile
Ali AtchaChief Executive Officer of Europe & UKProfile
Helen WisemanNon-Executive Chairman of the BoardProfile
Ron DufficyGlobal Chief Financial OfficerProfile
Gabriel EttensonGlobal Chief Technology OfficerProfile
Greg SmithGlobal Chief Information OfficerProfile
Kim BradleyWareJoint SecProfile
Glen ZurcherAccount DepartmentProfile
Paul BenhaimNon-Executive Chairman of the BoardProfile
Teresa ClearyGlobal General Counsel, Company SecretaryProfile
Rob HasselmanPres AmericasProfile
FCPA BECInterim OfficerProfile
Josephine LorenzGlobal ControllerProfile
Linda McLeodManaging DirectorProfile
Beata SilberGlobal InnovationProfile

About Elixinol Wellness Management Performance

The success or failure of an entity such as Elixinol Wellness often depends on how effective the management is. Elixinol Wellness management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elixinol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elixinol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. ELIXINOL GLOBAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.

Elixinol Wellness Workforce Analysis

Traditionally, organizations such as Elixinol Wellness use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elixinol Wellness within its industry.

Elixinol Wellness Manpower Efficiency

Return on Elixinol Wellness Manpower

Revenue Per Employee440.9K
Revenue Per Executive440.9K
Net Loss Per Employee660.7K
Net Loss Per Executive660.7K

Complementary Tools for Elixinol Stock analysis

When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets